98 related articles for article (PubMed ID: 8987677)
1. Estimation of pH and the number of lytic granules in a CD8+ CTL clone treated with an inhibitor of vacuolar type H(+)-ATPase concanamycin A.
Kataoka T; Sato M; Kondo S; Nagai K
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1729-31. PubMed ID: 8987677
[TBL] [Abstract][Full Text] [Related]
2. Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.
Kataoka T; Takaku K; Magae J; Shinohara N; Takayama H; Kondo S; Nagai K
J Immunol; 1994 Nov; 153(9):3938-47. PubMed ID: 7930604
[TBL] [Abstract][Full Text] [Related]
3. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
4. Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH.
Kataoka T; Togashi K; Takayama H; Takaku K; Nagai K
Immunology; 1997 Jul; 91(3):493-500. PubMed ID: 9301542
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a series of vacuolar type H(+)-ATPase inhibitors on CTL-mediated cytotoxicity.
Togashi K; Kataoka T; Nagai K
Immunol Lett; 1997 Mar; 55(3):139-44. PubMed ID: 9161879
[TBL] [Abstract][Full Text] [Related]
6. Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1.
Palokangas H; Ying M; Väänänen K; Saraste J
Mol Biol Cell; 1998 Dec; 9(12):3561-78. PubMed ID: 9843588
[TBL] [Abstract][Full Text] [Related]
7. FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation.
Kataoka T; Yamada A; Bando M; Honma T; Mizoue K; Nagai K
Immunology; 2000 Jun; 100(2):170-7. PubMed ID: 10886392
[TBL] [Abstract][Full Text] [Related]
8. Identification of low molecular weight probes on perforin- and Fas-based killing mediated by cytotoxic T lymphocytes.
Kataoka T; Taniguchi M; Yamada A; Suzuki H; Hamada S; Magae J; Nagai K
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1726-8. PubMed ID: 8987676
[TBL] [Abstract][Full Text] [Related]
9. Visualization of acidic compartments in cultured osteoclasts by use of an acidotrophic amine as a marker for low pH.
Inoue M; Yoshida H; Akisaka T
Cell Tissue Res; 1999 Dec; 298(3):527-37. PubMed ID: 10639743
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing of pro-opiomelanocortin occurs in acidifying secretory granules of AtT-20 cells.
Tanaka S; Yora T; Nakayama K; Inoue K; Kurosumi K
J Histochem Cytochem; 1997 Mar; 45(3):425-36. PubMed ID: 9071324
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N
Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the vacuolar proton-translocating ATPase in multiple steps of the endo-lysosomal system and in the contractile vacuole system of Dictyostelium discoideum.
Temesvari LA; Rodriguez-Paris JM; Bush JM; Zhang L; Cardelli JA
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1479-95. PubMed ID: 8799835
[TBL] [Abstract][Full Text] [Related]
13. Prodigiosin 25-C suppression of cytotoxic T cells in vitro and in vivo similar to that of concanamycin B, a specific inhibitor of vacuolar type H(+)-ATPase.
Lee MH; Kataoka T; Magae J; Nagai K
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1417-21. PubMed ID: 7549091
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
[TBL] [Abstract][Full Text] [Related]
15. Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.
Woo JT; Ohba Y; Tagami K; Sumitani K; Yamaguchi K; Tsuji T
Biol Pharm Bull; 1996 Feb; 19(2):297-9. PubMed ID: 8850326
[TBL] [Abstract][Full Text] [Related]
16. [Bafilomycins and related compounds as vacuolar H(+)-ATPase inhibitors].
Moriyama Y; Futai M; Yoshimori T; Yamamoto A; Tashiro Y
Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):2000-11. PubMed ID: 8210440
[No Abstract] [Full Text] [Related]
17. Concanamycin A: a powerful inhibitor of enveloped animal-virus entry into cells.
Guinea R; Carrasco L
Biochem Biophys Res Commun; 1994 Jun; 201(3):1270-8. PubMed ID: 8024571
[TBL] [Abstract][Full Text] [Related]
18. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells.
Guinea R; Carrasco L
J Virol; 1995 Apr; 69(4):2306-12. PubMed ID: 7884876
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of a vacuolar-type H+-ATPase in the plasma membrane and intracellular vacuoles of Trypanosoma cruzi.
Benchimol M; De Souza W; Vanderheyden N; Zhong L; Lu HG; Moreno SN; Docampo R
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):695-702. PubMed ID: 9620872
[TBL] [Abstract][Full Text] [Related]
20. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells.
Papini E; Bugnoli M; De Bernard M; Figura N; Rappuoli R; Montecucco C
Mol Microbiol; 1993 Jan; 7(2):323-7. PubMed ID: 8446034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]